Ireland· IE-PA-PA23460/001/002
Temgesic 300 micrograms/ml, solution for injection
A buprenorphine product containing buprenorphine hydrochloride, registered in Ireland by Eumedica Pharmaceuticals GmbH. The same ATC class is registered in 13 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Buprenorphine is registered in 13 of 19 countries.
Countries holding a registration under ATC N02AE01 (buprenorphine), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Buprenorphine · ATC N02AE01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of buprenorphine costs, country by country.
Normalised to the WHO defined daily dose (1.2 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Buprenorphine · price per daily dose (1.2 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.77
The record
At a glance
HPRA (Ireland)- Active substance
- Buprenorphine hydrochloride
- Manufacturer
- Eumedica Pharmaceuticals GmbH
- Country
- Ireland (IE)
- ATC code
- N02AE01
- ATC class
- Buprenorphine
- Defined daily dose
- 1.2 mg, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA23460/001/002
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
378 interactions on record for buprenorphine.
Graded by severity as the source publishes them — 59 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Buprenorphine · interactions on record
378 records
- 59 severe
- 253 moderate
- 2 minor
- 52 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- DronabinolA04AD10severe
12 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Buprenorphine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandBupaq Multidose vetVetViva Richter GmbH
- CzechiaADDNOKI-GEN, LDA, Caparica
- United KingdomBunov 10micrograms/hour transdermal patchesGlenmark Pharmaceuticals Europe Ltd
- United StatesBELBUCABioDelivery Sciences International Inc
- SwedenBuprefarm 10 mikrogram/timme DepotplåsterOrifarm Generics A/S
- NetherlandsBuprenorfine G.L. Pharma 0,2 mg tabletten voor sublinguaal gebruikG.L. Pharma GmbH
- GermanyAcimaphinLuye Pharma Ag
- BelgiumBuprenorfine Sandoz 35 µg/hSandoz
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Astec, Bupensan
- Belgium · Temgesic, Transtec
- Bulgaria · Бупренорфин G.L., Бупренорфин Актавис
- Cyprus · Buvera
- Czechia · Addnok, Buprenorfin Stada
- Germany · Acimaphin, Acinorphin
- Denmark · Buprefarm, Bupremyl
- Estonia · Buprenorphine G.L. Pharma
- Spain · Buprenorfina Andrómaco, Buprenorfina Sandoz
- Finland · Buprefarm, Bupremyl
- France · Bupensan, Buprenorphine Arrow
- United Kingdom (Northern Ireland) · Addnok, Bunov
- Greece · Buprenal, Buvera
- Croatia · Buprenorfin Alkaloid, Buprenorfin Sandoz
- Iceland · Buprenorphine Alvogen, Buprenorphine Neuraxpharm
- Italy · Buprenorfina Molteni, Buprenorfina Sandoz
- Liechtenstein · Buprenorphine Neuraxpharm, Buvidal
- Luxembourg · Temgesic, Temgesic Sublingualis
- Latvia · Buprenorphine G.L. Pharma
- Malta · Buprenorphine Aspire Pharma (Malta), Natzon
- Netherlands · Buprenorfine, Buprenorfine 1a Pharma
- Norway · Bugnanto, Buprefarm
- Poland · Bunondol, Bunorfin
- Portugal · Buprenorfina, Buprenorfina Aurovitas
- Sweden · Buprefarm, Buprenorfin Actavis
- Slovenia · Addnok, Buprenorfin Alkaloid-Int
- Slovakia · Bupretec, Noprex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cd879f5d-5489-49e4-8fa7-c9a821cfb6b8 GET /v1/drugs/cd879f5d-5489-49e4-8fa7-c9a821cfb6b8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"N02AE",
"N02AE01"
],
"strength": null,
"pa_number": "PA23460/001/002",
"substances": [
"Buprenorphine hydrochloride"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Not marketed",
"authorised_at": "01/02/2019",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about buprenorphine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.